Co-Authors
This is a "connection" page, showing publications co-authored by ANDRAS HECZEY and JENNIFER FOSTER.
Connection Strength
1.312
-
The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience. Pediatr Blood Cancer. 2024 Nov; 71(11):e31214.
Score: 0.229
-
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020. Cancer Epidemiol. 2024 Oct; 92:102610.
Score: 0.228
-
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020. medRxiv. 2024 Apr 05.
Score: 0.224
-
A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019. Pediatr Blood Cancer. 2024 Jan; 71(1):e30732.
Score: 0.217
-
Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer. 2022 10; 69(10):e29763.
Score: 0.197
-
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.
Score: 0.174
-
Pediatric Oncology Patients With Vincristine-Induced Recurrent Laryngeal Nerve Palsy: Two Case Reports and a Brief Review of Literature. Ear Nose Throat J. 2021 Dec; 100(10):NP459-NP463.
Score: 0.043